Your session is about to expire
← Back to Search
Vancomycin for Multiple Sclerosis
Study Summary
This trial will investigate whether vancomycin can help treat MS by altering the gut microbiome and reducing neuroinflammation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have not received any treatment for my condition.I have an autoimmune disease like lupus, rheumatoid arthritis, or diabetes.I understand the risks and benefits of the trial and can consent.I have had surgery on my intestines before.I have used pre-/probiotics or corticosteroids in the last month.I have an eating disorder like anorexia, bulimia, or binge eating.I haven't had gastroenteritis recently and don't have chronic infections like hepatitis or HIV.I have irritable bowel syndrome or constipation.I am between 18 and 50 years old.I have been treated with drugs that lower my immune system.I cannot take vancomycin due to kidney issues, hearing problems, or an allergy.I was recently diagnosed with MS and started having symptoms within the last year.
- Group 1: Placebo
- Group 2: Vancomycin
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is it possible for senior citizens to become part of this investigation?
"The age requirement for this clinical trial mandates that all candidates must be over 18 years of age and below 45."
What has been the verdict from the Food and Drug Administration concerning Vancomycin?
"There is only a smattering of data attesting to vancomycin's safety, so it earned the lowest score possible on our scale (1)."
Are there still opportunities for patients to join this research experiment?
"Affirmative, according to information provided on clinicaltrials.gov this research is currently recruiting participants. The trial was first publicized on November 8th 2022 and has since been updated on the 21st of that same month. 40 patients are required for a single medical centre."
Are there any qualifying criteria for participating in this medical research?
"This medical study is seeking 40 individuals aged 18-45 who have recently been diagnosed (within 6 months) with multiple sclerosis, and are yet to receive treatment. These patients must also be intending to use a disease modifying therapy for their MS."
What is the estimated number of participants in this research initiative?
"Affirmative. The information on clinicaltrials.gov reveals that this medical study, which was first published on November 8th 2022, is currently recruiting participants. 40 individuals are being sought at a single trial site."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger